Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice

This publication has 35 references indexed in Scilit:

• Interleukin-12: Potential Clinical Applications in the Treatment and Prevention of Infectious Diseases
  Drugs, 1996
• Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo
  European Journal of Immunology, 1995
• The role of interleukin 12 in the immune response, disease and therapy
  Immunology Today, 1994
• Influenza A virus replication is inhibited by tumor necrosis factor-α in vitro
  Archiv für die gesamte Virusforschung, 1994
• Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cells
  European Journal of Immunology, 1993
• Interleukin-12 and its role in the generation of TH1 cells
  Immunology Today, 1993
• Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge
  The Journal of Infectious Diseases, 1993
• Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.
  The Journal of Experimental Medicine, 1992
• Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus
  Journal of General Virology, 1990
• TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
  Annual Review of Immunology, 1989